Brokers upbeat on Sanofi SA despite economic uncertainty

The Sanofi SA (EPA:SAN) share price has risen by 3.38% over the past month and it’s currently trading at €100.1. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Sanofi SA currently has:

• 10 Buy recommendations

• 6 Hold recommendations

• 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO EPA:SAN »

Researching beyond broker forecasts

At its current price of €100.1, shares in Sanofi SA are trading at a discount of -5.62% to its 52 week high price. The 1-year performance of the shares has been 15.4%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Sanofi SA it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Sanofi SA that you can find out about here.